Artwork
iconShare
 
Manage episode 521305474 series 2081705
Content provided by C&EN and Engineering News. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by C&EN and Engineering News or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In the first episode of our second season, hosts David Anderson and Gina Vitale travel back in time to relive three historical moments that led to blockbuster drugs like Ozempic and Wegovy. They also talk with C&EN reporter Aayushi Pratap about how future GLP-1 drugs may expand on the current slate of options.

C&EN's latest podcast, Inflection Point, leans on our 100-year archive to trace headline topics in science today back to their disparate and surprising roots. In each episode, we explore three lesser-known moments in science history that ultimately led us to current-day breakthroughs. With help from expert C&EN reporters, this new show examines how discoveries from our past have shaped our present and will change our future.

Subscribe to Inflection Point now on Apple Podcasts, Spotify, or wherever you get your podcasts.

  continue reading

101 episodes